MBXAX | MBXIX | MBXAX / MBXIX | |
Total Expense Ratio | 2.28 | 2.03 | 112% |
Annual Report Gross Expense Ratio | 2.28 | 2.03 | 112% |
Fund Existence | 10 years | 10 years | - |
Gain YTD | 3.971 | 4.173 | 95% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.45B | 8.45B | 100% |
Annual Yield % from dividends | 1.62 | 1.82 | 89% |
Returns for 1 year | 5.04 | 5.32 | 95% |
Returns for 3 years | 7.78 | 8.65 | 90% |
Returns for 5 years | 48.59 | 50.54 | 96% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFDIX | 57.64 | 0.37 | +0.65% |
American Century Large Cap Equity Inv | |||
PREIX | 175.30 | 0.92 | +0.53% |
T. Rowe Price Equity Index 500 | |||
LRSTX | 20.62 | 0.09 | +0.44% |
Lord Abbett Small Cap Value R5 | |||
RYOIX | 76.94 | 0.30 | +0.39% |
Rydex Biotechnology Inv | |||
QRSAX | 43.82 | -0.02 | -0.05% |
FPA Queens Road Small Cap Value Advisor |